ERS Presidential Summit 2018: multimorbidities and the ageing population
- PMID: 31579675
- PMCID: PMC6759575
- DOI: 10.1183/23120541.00126-2019
ERS Presidential Summit 2018: multimorbidities and the ageing population
Abstract
As the average age of the population increases, so will the prevalence of chronic respiratory diseases and associated multimorbidity. This will result in a more complex clinical environment. Part of the solution will be to allow patients to be co-creators in the design of their care. It will also require clinicians to shift in their current approaches to care, step out of the disease- or pathology-oriented approach and embrace new ideas. In an effort to prepare the respiratory community for the challenge, we reflect on concepts to empower patients via multidisciplinary systems, new technologies and transition from end-of-life care to advanced care planning.
Copyright ©ERS 2019.
Conflict of interest statement
Conflict of interest: M. Gaga has received departmental grants and honoraria from AZ, GSK, Menarini, Chiesi, Novartis, BMS, MSD, Roche, Elpen and Pharmaten outside of this work. Conflict of interest: P. Powell is an employee of the European Lung Foundation. Conflict of interest: M. Almagro reports nonfinancial support from Polyphor outside the submitted work. Conflict of interest: I. Tsiligianni reports personal fees from Novartis, grants and personal fees from GSK, and personal fees and other support from Boehringer Ingelheim, outside the submitted work. Conflict of interest: Dr. Loukides has nothing to disclose. Conflict of interest: Dr. Roca has nothing to disclose. Conflict of interest: M. Cullen has nothing to disclose. Conflict of interest: A.K. Simonds has nothing to disclose. Conflict of interest: B. Ward is an employee of the European Respiratory Society. Conflict of interest: I. Saraiva has nothing to disclose. Conflict of interest: T. Troosters has nothing to disclose. Conflict of interest: C. Robalo Cordeiro has nothing to disclose.
Figures





Comment in
-
ERS Presidential Summit: redesigning the future of patient care.ERJ Open Res. 2019 Sep 25;5(3):00139-2018. doi: 10.1183/23120541.00139-2018. eCollection 2019 Jul. ERJ Open Res. 2019. PMID: 31584568 Free PMC article.
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
A Digital Health Platform for Integrated and Proactive Patient-Centered Multimorbidity Self-management and Care (ProACT): Protocol for an Action Research Proof-of-Concept Trial.JMIR Res Protoc. 2021 Dec 15;10(12):e22125. doi: 10.2196/22125. JMIR Res Protoc. 2021. PMID: 34914613 Free PMC article.
-
Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.Geriatr Gerontol Int. 2021 Aug;21(8):601-613. doi: 10.1111/ggi.14201. Epub 2021 Jul 1. Geriatr Gerontol Int. 2021. PMID: 34212470
-
Network medicine, multimorbidity and the lung in the elderly.Eur Respir J. 2014 Sep;44(3):775-88. doi: 10.1183/09031936.00078714. Epub 2014 Jul 25. Eur Respir J. 2014. PMID: 25063242 Review.
-
Computer technologies to integrate medical treatments to manage multimorbidity.J Biomed Inform. 2017 Nov;75:1-13. doi: 10.1016/j.jbi.2017.09.009. Epub 2017 Sep 21. J Biomed Inform. 2017. PMID: 28942139 Review.
References
-
- MacNee W, Rabinovich RA, Choudhury G. Ageing and the border between health and disease. Eur Respir J 2014; 44: 1332–1352. - PubMed
-
- Barnett K, Mercer SW, Norbury M, et al. . Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380: 37–43. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials